Endothelins (ET) produce endothelium-dependent vasodilation through nitric oxide (NO) synthesis. The present study was designed to elucidate the cellular mechanism by which ET induces synthesis and release of endothelium-derived NO by cultured bovine endothelial cells (EC). Binding studies revealed that bovine EC membrane had the binding sites of a novel agonist (BQ3020) for non-isopeptide-selective receptor subtype (ETB). Affinity labeling studies showed a major labeled band with the apparent molecular mass of 50 kD. Northern blot analysis demonstrated the expression of mRNA for ETB receptor. BQ3020 rapidly and dose dependently induced formation of inositol-1,4,5-triphosphate and increased intracellular Ca2+ concentrations in fura-2-loaded cells. Concomitantly, BQ3020 dose dependently stimulated production of both nitrate/nitrite (NOx) and cyclic GMP, a highly significant correlation existed between NOx and cGMP production.
Introduction
Endothelin-1 (ET-1)' is a potent endothelium-derived vasoconstrictor peptide originally isolated from culture media of porcine vascular endothelial cells (EC) (1) . Subsequent human genomic cDNA cloning revealed three distinct ET isopeptides, designated ET-1, ET-2 and ET-3 (2) . Compared with the equipotent vasoconstrictor/pressor activities of ET-I and ET-2, ET-3 has less vasoconstrictor/pressor activity but the most potent initial depressor response (2) , suggesting the existence of receptor subtypes. Recently, cDNA cloning of ET receptors from bovine and rat lung has revealed at least two distinct subtypes (3, 4) : one selective for ET-l and ET-2 (ETA) and the other non-isopeptide-selective (ETB). Both receptor subtypes comprise seven transmembrane domains common to the Gprotein-coupled receptors. It has been suggested that vascular smooth muscle has ETA receptors that mediate contraction, while vascular EC has ETB receptors that may be involved in the vasodilation (3, 4) . Very recently, several agonists selective for ETB receptors have been developed (5) . One of these, BQ3020, a linear ET analog (N-acetyl-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp), is highly selective for the ETB receptors (6) ; BQ3020 binds to the ETB receptors several thousands times more selectively than to the ETA receptors.
Endothelium-derived relaxing factor (EDRF) or nitric oxide (NO) (7, 8) is a potent vasodilator with anti-platelet aggregation property produced by a variety of cells including ECs, vascular smooth muscle, macrophages, and neuronal cells (9) . The formation of NO is catalyzed from L-arginine by a NADPH-dependent dioxygenase, termed NO synthase (NOS). There exist at least two distinct isoforms of NOS (9) ; one is a constitutive, Ca2+/calmodulin-dependent enzyme present mainly in ECs and brain, while the other is an inducible, Ca2+/ calmodulin-independent enzyme activated by cytokines that is found predominantly in macrophages and vascular smooth muscle cells.
It has been shown that ET-3 is a vasodilator rather than a vasoconstrictor in the isolated perfused rat mesentery via production and release of EDRF/NO (10) . We have recently shown that ET-3-induced vasodilation is ascribed mainly to EDRF/NO in isolated porcine pulmonary artery in vitro ( 11 ) . In cultured bovine ECs, we have demonstrated that ET-3, but not ET-1, stimulates receptor-mediated phosphoinositide breakdown, which increases cytosolic free Ca2+ concentrations ([Ca2+ j]i) (12) and activates soluble guanylate cyclase, possibly by the generation of EDRF/NO (13) . However, the cellular mechanism by which ET stimulates the synthesis and release of EDRF/NO remains largely unknown. In the present study, we have attempted to ascertain whether vascular ECs predominantly express ETB receptors using receptor binding study with a novel ETB receptor agonist and Northern blot analysis, and 1. Abbreviations used in this paper: BAPTA, N,N,N',N'-tetraacetic acid; [Ca2`]j, cytosolic free Ca2`concentration; cNOS, Ca2`/calmodulin-dependent constitutive enzyme; DSS, disuccinimidyl suberate; EC, endothelial cell; EC5, halfmaximal stimulation; EDRF, endotheliumderived relaxation factor; ET, endothelin; ETA, ET receptor selective for ET-1 and ET-2; ETB, non-isopeptide-selective receptor subtype; H-7, 1-5-isoquinolinylsulfonyl-2-methylpiperazine; IBMX, 3-isobutyl-1-methylxanthine; iNOS, Ca2+/calmodulin-independent cytokine-inducible enzyme; IP3, inositol-1,4,5-triphosphate; LNMMA, NG-monomethyl-L-arginine; NO, nitric oxide; NOS, nitric oxide synthase; NOx, nitrite/nitrate; PTX, pertussis toxin; W-5, N-(6-aminohexyl)-1-naphthalene-sulfonamide; W-7, N-(6-aminohexyl)-6-chloro-1-naphthalenesulfonamide. to elucidate the intracellular mechanism(s) responsible for NOS activation using an ETB receptor agonist in cultured bovine ECs.
Methods
Drugs. Synthetic BQ3020 (10) was generously provided by Dr. M. Ihara and Dr. M. Yano, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd. (Tsukuba, Japan). ET-1, ET-3, leupeptin, and pepstatin D were purchased from Peptide Institute (Osaka, Japan); N0monomethyl-L-arginine (LNMMA) and 3-isobutyl-I -methylxanthine (IBMX) from Calbiochem Corp. (La Jolla, CA); EDTA, EGTA, 1,2bis(2-aminophenoxy)ethane NNN',N'-tetraacetic acid (BAPTA), N-(6-aminohexyl)-l-naphthalene-sulfonamide (W-5), N-(6-aminohexyl)-6-chloro-l-naphthalenesulfonamide (W-7), 1-5-isoquinolinylsulfonyl 2-methylpiperazine (H-7), PMSF, disuccinimidyl suberate (DSS), and D-and L-arginine from Sigma Chemical Co. (St. Louis, MO); nicardipine from Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, Japan); pertussis toxin from Kaken Chemical (Tokyo, Japan); methylene blue from Schmidt GmbH (Stuttgart-Unterturkeim, Germany); and fura-2 acetoxymethyl ester from Dojin Chemical (Kumamoto, Japan).
Cell culture and incubation. ECs from bovine carotid artery were prepared and cultured in DME containing 10% FCS and antibiotics (100 U/ml penicillin, 100 Mg/ml streptomycin) at 370C in a humidified atmosphere of95% air and 5% CO2 (5, 6) . The cells were identified as ECs by the contact-inhibited monolayer growth with a "cobblestone" appearance and the presence of Factor VIII antigen detected immunocytochemically. After serial subculture with 0.05% trypsin and 0.02% EDTA, ECs harvested between the 8th and 12th passage were used in the experiments. Confluent cells were washed with HBSS that was replaced with fresh HBSS unless otherwise stated.
Binding study. Membranes from ECs were prepared by the same method as previously reported (14) . Briefly, bovine ECs and rat cerebellum were homogenized by a Polytron homogenizer (Kinematica AG Littau, Switzerland) in 20 mM phosphate buffer (130 mM NaCl, 1 mM EDTA, 0.2 mM PMSF, 10 g/ml pepstatin, 10 Mg/ml leupeptin), pH 7.5; then the mixture was washed, centrifuged, and resuspended in the same buffer. The membrane suspension (15-30 ,ug protein) was usually incubated with 25 pM ['251]BQ3020 (specific activity 2,000 Ci/mmol) (Amersham Japan, Tokyo, Japan) in the presence or absence of unlabeled peptides at 30°C for 30 min. After incubation, free radioactive ligand was removed by centrifugation. Radioactivity was measured with gamma counter (ARC-300; Aloca, Tokyo, Japan). Specific binding was determined by subtracting nonspecific binding in the presence of excess (106 M) unlabeled BQ3020 from total binding. Affinity labeling. Affinity labeling of [ 12511 ] BQ3020 to the EC membrane was performed as described previously (14) . Briefly, the membrane suspension (10 ,ug protein) was incubated with 750 pM [125I] BQ3020 at 30°C for 30 min in the presence or absence of excess amounts (10-6 M) ofunlabeled peptides, and DSS was added to a final concentration of I mM. The mixture was then incubated for 20 min at 25°C, followed by the addition of 2 M ammonium acetate to stop the reaction. The reaction mixture was subjected to SDS-PAGE in the presence of 5% 2-mercaptoethanol according to the method of Laemmli (15) . After electrophoresis, the gels were dried and exposed to film (X-Omat AR; Kodak, Rochester. NY) at -70°C for 5 d.
Northern blot analysis. RNA was extracted from bovine ECs by the acid guanidinium thiocyanate-phenol-chloroform method (16) . Briefly, ECs were homogenized in 10 ml guanidinium solution (4 M guanidinium thiocyanate, 25 mM sodium citrate, 0.5% sarcosyl, and 1% 2-mercaptoethanol) using a Polytron homogenizer and 1 ml 2 M sodium acetate (pH 4), 10 ml water-saturated phenol, and 2 ml chloroform-isoamyl alcohol mixture (49: 1) were added with through mixing and vortexing; the solution was cooled on ice for 15 min. After centrifugation at 1,000 g for 20 min, an aqueous phase containing RNA was transferred and precipitated with isopropyl alcohol at -20°C for 20 min. RNA was pelleted by centrifugation, washed with 70% ethanol, dissolved in diethylpyrocarbonate-treated water, and subjected to poly (A)' RNA selection. Poly(A)' RNA (10 Ig) was fractionated by formaldehyde/ 1.1% agarose gel electrophoresis and transferred to a nylon membrane (MagnaGraph; Micron Separations Inc., Westboro, MA).
Probe for bovine ETB receptor cDNAs (17) was labeled with 132P]-dCTP (Amersham International, Amersham, UK) by the randomprimed method, and incubated at 420C for 16 h with the membranes in a hybridization buffer containing I M NaCl/50% (vol/vol) formamide, 1% SDS, and 250 ,g/ml salmon sperm DNA. The membranes were washed with 0.3 M NaCl, 30 mM sodium citrate, and 1% SDS at 60'C, and they were autoradiographed on film (X-Omat AR; Rochester) at -80'C for 16 h.
Determination of nitrite/nitrate (NOx). Confluent ECs were usually incubated in Hanks' medium without phenol red at 370C for I min unless otherwise specified. Medium was removed and NOx concentration was determined by an autoanalyzer (TCI-NOX 1000; Tokyo Kasei Kogyo Co., Ltd., Tokyo, Japan) as recently described ( 18) . In brief, sample premixed with the carrier solution (0.07% EDTA, 0.03% NH4CI) was passed through a copperized cadmium reduction column, where NO; was reduced to NO0, which reacts with Griess reagent (one part 1% sulfonamide and one part 0.1% N-l-naphthylethylenediamine dihydrochloride/5% HCl) to form a purple azo dye (19) . Absorbence at 540 nm was detected by a flow-through visible spectrophotometer (model S/3250; Soma-Kogaku Co., Ltd., Tokyo, Japan) connected to a strip chart recorder. The limit of detection of NO was 0.2MgM (99% confidence)and intraassay and interassay coefficients of variation were 1.6% and 0.7%, respectively.
Determination of inositol-1,4,5-triphosphate (IP3). For measurement of IP3, confluent ECs were incubated at 37°C in HBSS containing 10 mM LiCl as reported ( 12, 13) . Incubation was terminated by the rapid removal of medium and the addition of ice-cold 15% TCA and the cells were placed on ice for 30 min. The TCA extract was washed with ethylether and neutralized with 1N sodium acetate. IP3 levels were determined with an IP3 assay kit (New England Nuclear, Boston, MA).
Determination of intracellular cyclic guanosine monophosphate (cGMP). For measurement of cGMP, confluent cells were incubated at 37°C for 10 min in HBSS containing 0.5 mM IBMX as described previously ( 13) . After extraction with 6% TCA, the concentration of intracellular cGMP was determined with a cGMP RIA kit (New England Nuclear). Measurement ofcytosolicfree Ca2" concentration ([ Ca2 ]J). Measurement of [Ca2+]i was measured by the Ca2+-fura-2 fluorescence method as described previously (20) . After incubation in serum-free DME for 24 h, ECs were trypsinized and incubated with 4 MM fura-2 acetoxymethyl ester at 37°C for 20 min in buffered physiological salt solution, essentially as reported previously (20) . The Ca2"-fura-2 fluorescence of the suspended cells ( 2 X 106 cells/ml) was measured by a spectrofluorometer (CAF-100; JASCO Co., Ltd., Tokyo, Japan) using excitation at 340 and 380 nm and emission at 500 nm. Values of the nonspecific binding was < 10% of the total binding (data not shown). As shown in Fig. 1 A, unlabeled BQ3020 and ET-3 equally displaced radioligand binding to EC membranes, while ET-l was less potent; the apparent Kd was 2 x 10-10 M and the Bma,, was 62 fmol/mg protein. In contrast, the binding of[ "25I]-BQ3020 to rat cerebellar membranes was equally inhibited by unlabeled BQ3020, ET-3, and ET-l ( Fig. 1 B) ; the apparent Kd and Bm. were 2 x 1010 M and 1.6 pmol/mg protein, respectively.
SDS-PAGE after affinity labeling of '25I-labeled BQ3020 to EC membranes by bifunctional crosslinker DSS revealed one major labeled band with an apparent molecular mass of 50 kD ( After addition of IO-7 M BQ3020, confluent cells were incubated for indicated times. IP3 generation was deter-60 mined. Each point with bar shows the mean ±SEM (n = 6). Northern blot analysis. Northern blot hybridization ofpoly (A)' RNA from bovine ECs with cloned cDNA for bovine ETB receptor as a probe revealed a distinct band (4.8 kb) corresponding to the size of ETB receptor mRNA (Fig. 3) .
IP3 production and [Ca2"], increase by ETB agonist. BQ3020 rapidly stimulated IP3 production, which peaked at 15 s and then declined almost to basal levels by 1 min (Fig. 4 ).
BQ3020 also induced an immediate increase in [Ca2"]j, which peaked at 15 s and returned to basal levels after 1 min (Fig. 5) ; the ETB agonist-induced increase in [Ca2+Ji was not affected by pretreatment with nicardipine or EGTA. As shown in Fig. 6 , BQ3020 similarly stimulated IP3 production and [Ca2+]i increase in a dose-dependent fashion (l0-'-10-7 M); the approximate doses of BQ3020 for half maximal stimulation (EC50) and maximal stimulation were 5 X 10-9 and 10-7 M, respectively.
Production of NOx and cGMP by ETB agonist. BQ3020 rapidly stimulated production and release of NOx, which B03020 ( 10-6) Figure 5 . Representative tracings show changes of Ca2+-fura-2 fluorescence by ETB agonist BQ3020 in cultured bovine endothelial cells. Cell suspensions loaded with fura-2 were challenged with 106 M BQ3020 pretreated without (A), and with 10-6 M nicardipine (B) and3 x 10-3M EGTA (C). Calculated values for [Ca2+]i are shown on the ordinates. peaked at 1 min and lasted for 2 20 min, and similarly stimulated cGMP generation, which peaked at 5-10 min in the presence of the phosphodiesterase inhibitor IBMX (data not shown). As shown in Fig. 7 , BQ3020 dose dependently ( 10-'-I0 -7 M) stimulated production of both NOx and cGMP with almost comparable EC50 value (-2 X 10-8 M). There was a highly significant (P < 0.001) correlation (r = 0.93) between NOx and cGMP production. Methylene blue ( l0-3 M), a soluble guanylate cyclase inhibitor, completely blocked BQ3020induced cGMP generation (data not shown).
Arginine as a substrate for NOx production. To ascertain whether ETB agonist-induced NOx production is mediated by NOS, the effect of the stereospecific NOS inhibitor, LNMMA, on NOx production was studied. The BQ3020-induced NOx production was completely inhibited by 4 x and this effect was reversed by the simultaneous addition of 10-2 M L-arginine, but not by 10-2 M D-arginine ( Fig. 8 ). Involvement of pertussis toxin (PTX) -sensitive G-protein(s). To determine whether PTX-sensitive G-protein(s) is involved in ETB receptor-mediated NO synthesis, cultured bovine ECs were pretreated with PTX (100 ng/ml) for 6 h, and the effect of the ETB agonist on NOx and cGMP production was studied ( Fig. 9 ). BQ3020-induced production of both NOx and cGMP was abolished in a similar fashion by pretreatment with PTX, while PTX alone had no effect on the basal production of NOx and cGMP. Role of Ca2+/calmodulin system in NOx production. To elucidate whether ETB receptor-mediated NOx synthesis requires Ca2+ from an intracellular and/or extracellular source, the effects of an intracellular Ca2+ chelator (BAPTA) and an extracellular Ca2+ chelator (EGTA) on NOx production were studied (Table I) alone and in combination with either an intracellular Ca2" chelator (BAPTA), an extracellular Ca2`chelator (EGTA), a relatively selective calmodulin inhibitor (W-7), a nonselective calmodulin inhibitor (W-5), and a protein kinase C inhibitor (H-7) in concentrations as indicated. NOx released into medium was measured as described in Methods. Each value is the mean ± SEM (n = 6). * P < 0.05 vs. control. 3 x 10-3 M BAPTA completely abolished NOx production stimulated by 10-6 M BQ3020, whereas removal ofextracellular Ca2" by 3 X 10-3 M EGTA had no effect.
The effects ofcalmodulin inhibitors and a protein kinase C inhibitor on ETB agonist-induced NOx production were also examined ( Table I) . The BQ3020-induced NOx production was significantly decreased by a relatively selective calmodulin inhibitor (W-7), but not by either a nonselective calmodulin inhibitor (W-5) or a protein kinase C inhibitor (H-7).
Discussion
Recent cDNA cloning studies have revealed the existence of at least two subtypes ofET receptors, termed ETA and ETB (3, 4) ; ETA receptor shows selective affinity for ET-1, whereas ETB receptor shows nonselective affinity for ET isopeptides. It has been suggested that vascular smooth muscle expresses ETA receptors that mediate contraction, while vascular endothelium expresses ETB receptors that mediate relaxation, possibly via production of EDRF/NO and prostacyclin (3, 4) . Recently, several analogs selective for ETB receptors have been synthesized (5), among which BQ3020 has been shown to be the most potent, stable, and selective agonist for ETB receptor thus far reported (6); BQ3020 displaces [12511 ]ET-1 binding to the ETB receptor in the porcine cerebellar membranes with a selectivity 4,700 times greater than that to the ETA receptor in vascular smooth muscle. We have confirmed that [125I]BQ3020 binding to rat cerebellar membrane is inhibited equipotently by BQ3020, ET-1, and ET-3 with high affinity similar to that of porcine cerebellar membrane (6) .
The present binding study clearly demonstrated the presence of binding sites for ETB agonist in cultured bovine ECs with high affinity (KD-2 X 10-10 M) comparable to that of rat cerebellar membranes. In contrast to the complete and equal binding inhibition by ET isopeptides in cerebellar membranes, unlabeled ET-1 failed to displace [1251] BQ3020 completely from its binding site in EC membranes. The same apparent lack of complete displacement by unlabeled ET-1 has already been shown in [ '25I ] ET-3 binding to cultured bovine ECs ( 12) and human ECs (22) . Several possible mechanisms may account for the anomalous behavior of ET-1 in cultured ECs.
First, this may be caused by differences in the dissociation rates ofET isopeptides. Indeed, it has been reported that the dissociation of [1251I]ET-l bound to Swiss 3T3 fibroblasts is much slower than that of [ 125I ] ET-2 (23) . Second, this may be ascribable to downregulation ofthe ETB receptor by endogenous ET-1 constitutively secreted by ECs as previously suggested ( 14) . It has recently been shown that pretreatment of cultured human ECs with phosphoramidon, a putative ET-converting enzyme inhibitor, led to an increase in the binding capacity of the ETB receptor that interacts equally with ET-1 and ET-3 (24), suggesting upregulation of endothelial ETB receptor after blocking processing from big ET-l to ET-1. We have confirmed these observations in that bovine endothelial ETB receptor exhibits equal binding affinity for ET-1 and ET-3 in phosphoramidontreated cells (unpublished observation). Third, there may be another receptor subtype in addition to the ETA and ETB receptors that prefers ET-3 over ET-1. However, there have been no reports thus far on the isolation of cDNA clones encoding an ET-3 selective receptor (ETc) (25); Southern blot analysis of human genomic DNA using ETA and ETB receptor cDNA probes revealed only two different genomic DNA fragments even under low stringency conditions (26) , suggesting that mammalian genomes contain only two closely related ET receptor genes, probably for the ETA and ETB receptors. Should a third novel receptor gene exist in mammalian genomes, it has little if any similarity to the two known receptors. Whatever the mechanism involved, our study shows that ET-3 preferentially interacts with ETB receptor in cultured bovine ECs.
Affinity labeling experiments to visualize receptor molecules on SDS-PAGE after covalent binding of BQ3020 to EC membranes by a bifunctional cross-linker revealed one major labeled band with the apparent molecular mass of 50 kD, whose size appears to be comparable to that ofthe ETB receptor (4, 14, 17) . Northern blot analysis of poly(A)+ RNA from cultured bovine EC verified the expression ofthe ETB receptor gene in these cells.
In our previous study ( 12) , we showed that ET-3 stimulates receptor-mediated phosphoinositide breakdown, which triggers intracellular Ca2l mobilization in cultured bovine ECs. Subsequent studies have shown that ET-3 stimulates soluble guanylate cyclase activity, possibly resulting from NO formation in cultured bovine ECs (13) . The present study clearly demonstrated that BQ3020, a more selective ETB agonist than ET-3, rapidly and dose dependently stimulated phosphoinositide breakdown and [Ca2"]i increase in cultured bovine ECs.
These findings are consistent with our previous observation that ET-3 induces receptor-mediated phosphoinositide breakdown and [Ca2+]i increase in the same cell preparation ( 12) . The coincident times of peak IP3 formation and [Ca2" i transient elicited by BQ3020 and the failure ofthe response, either by removal of extracellular Ca2" with EGTA or by blockade of voltage-dependent Ca2+ channels with nicardipine, strongly suggest that the [Ca2+]i increase derives mainly from IP3-mediated intracellular Ca2' release rather than Ca2+ influx from an extracellular source. Furthermore, the present study showed that an ETB agonist immediately and dose dependently stimulated NOx and cGMP production in cultured bovine ECs. The highly signifi-cant correlation between NOx production and cGMP generation and the inhibitory effect of methylene blue on cGMP generation in bovine ECs suggest that ETB agonist-induced NO production led to the stimulation of soluble guanylate cyclase within the same cells. However, the physiological function(s) of NO-induced cGMP generation in ECs remains unknown.
There appears to be a discrepancy between the apparent Kd for BQ3020 binding ( 2 X 10`1 M) and the EC50 values for IP3 formation and [Ca2J]i transient ( -5 X 10-9 M) and the corresponding values for NOx and cGMP production (-2 x 10-8 M). Such a discrepancy may be partly accounted for by the use of different incubation conditions (temperature and time) and preparations (cell membranes, dispersed cells, and monolayers). Alternatively, different cellular responses to the ETB agonist may be mediated via activation ofdifferent subpopulations of ETB receptors, although Scatchard analysis of BQ3020 binding revealed a single class of binding sites in EC membranes. It should be noted that there is also a discrepancy betwe'en the binding affinity of ETA receptor and ET-l-induced cellular responses, including IP3 formation, [Ca2+]i increase, and contraction in rat glomerular mesangial cells (27) . Both ETA and ETB receptor subtypes have seven hydrophobic membrane-spanning domains belonging to the superfamily of G-protein-coupled receptors (3, 4, 17) . Several types of Gproteins have been identified in cardiovascular tissues (28) . Pertussis toxin induces NAD-dependent ADP ribosylation of the a-subunit of several G-proteins (Gi, Go, and Gq). The present study revealed that pertussis toxin completely blocked ETB agonist-induced NOx and cGMP production in bovine ECs. In our previous study ( 13) , pertussis toxin was shown to block phosphoinositide breakdown and the [Ca2+]i increase stimulated by ET-3 in bovine ECs. These data are in contrast to findings with the ETA receptor in vascular smooth muscle, which is functionally coupled to phospholipase C-mediated phosphoinositide breakdown via pertussis toxin-insensitive Gproteins (29). Taken together, these observations suggest that the ETB receptor in vascular endothelium is functionally coupled to phospholipase C, possibly via pertussis toxin-sensitive G-protein(s) involved in synthesis and/or release of EDRF/NO. EDRF/NO is produced from L-arginine by NADPH-dependent NOS (8, 9) . The inhibition by LNMMA of ETB agonist-induced NOx production, as well as its reversal by L-arginine, but not by D-arginine, as demonstrated in this study, is consistent with the notion that NOS requires stereoselectivity for the L-enantiomer of arginine as a substrate to generate NO (30) . At least two isoforms of NADPH-dependent NOS have been found in a variety of tissues and cells (9) . Brain NOS is a constitutive Ca2+/calmodulin-dependent enzyme (cNOS), the entire structure of which has been elucidated by cDNA cloning ofrat brain (31 ) . Macrophage NOS, on the other hand, is a Ca2+/calmodulin-independent cytokine-inducible enzyme (iNOS), of which the entire structure has recently been determined by cDNA cloning of murine macrophages (32) . Both isoforms share 50% sequence homology and comprise binding sites for NADPH, flavin mononucleotide, and flavin adenine dinucleotide. Very recently, a distinct cNOS isoform from bovine ECs has been cloned (33) , which shows 50-60% sequence identity with murine macrophage iNOS and rat brain cNOS isoforms.
The present study clearly showed that ETB receptor-mediated NO synthesis in bovine EC requires Ca2" and calmodu-lin, based on the observations that BQ3020-induced NOx production is completely blocked by an intracellular Ca2" chelator (BAPTA), but not by an extracellular Ca2+ chelator (EGTA), and by a relatively selective calmodulin inhibitor (W-7), but not by a less selective calmodulin inhibitor (W-5) or a protein kinase C inhibitor (H-7). It has been suggested that endothelial NOS is constitutive and dependent on Ca2+/calmodulin (9, 34) . In fact, cNOS isoforms from bovine ECs (33) and rat brain (31), but not iNOS from murine macrophages (32), contain binding sites for calmodulin within the molecule. From these findings, we conclude that vascular endothelium contains cNOS that is activated by a Ca2+/calmodulin-dependent pathway resulting from ETB receptor-mediated phosphoinositide breakdown and Ca2+ mobilization via pertussis toxin-sensitive G-protein(s).
